Background: To our knowledge there has been no study investigating the impact of freeze-dried strawberry (FDS) supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes (T2D). Objective: This study was carried out to determine the effects of FDS supplementation on glycemic control, biomarkers of oxidative stress, inflammation and serum total antioxidant status in subjects with T2D compared to matched control subjects. Methods: Thirty-six subjects with T2D (23 females; mean body mass index 27.90 ± 3.7; mean age 51.57 ± 10 years) were randomly divided into two groups. The treatment group consumed 2 cups of FDS beverage (50 g of FDS is equivalent to 500 g of fresh strawberries) or macronutrient matched placebo powder with strawberry flavor daily for 6 weeks in a randomized double-blind controlled trial. Anthropometric measurements, dietary intakes, hemoglobin (Hb)A1c, antioxidant status, C-reactive protein and malondialdehyde (MDA) levels were assessed at baseline and 6 weeks post-intervention. Results: FDS supplementation significantly decreased C-reactive protein levels as a biomarker of inflammation (2.5 vs. 2.04 mg/l, p < 0.05) and lipid peroxidation in the form of MDA (3.36 vs. 2.7 nmol/ml, p < 0.05) at 6 weeks compared to the baseline. Moreover, supplementation led to a decreasing trend in HbA1c (-5.7%, p < 0.05) and significant increase in total antioxidant status in the FDS group (1.44 vs. 1.26 mmol/l, p < 0.01) compared to the placebo group. No significant changes were observed in serum glucose concentrations and anthropometric indices. Conclusions: FDS improved glycemic control and antioxidant status, and reduced lipid peroxidation and inflammatory response in patients with T2D. Supplementation with freeze-dried berry products, as natural sources of antioxidants with low glycemic index, could be considered as an adjunctive therapy in ameliorating metabolic complications of T2D.

1.
DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
2.
Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
3.
Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V: Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med 1996;13:715-719.
4.
Bast A, Wolf G, Oberbaumer I, Walther R: Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 2002;45:867-876.
5.
Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 2003;52:1-8.
6.
Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823.
7.
Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-2072.
8.
Kuyvenhoven JP, Meinders AE: Oxidative stress and diabetes mellitus pathogenesis of long-term complications. Eur J Intern Med 1999;10:9-19.
9.
Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A: The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab 2003;88:2422-2429.
10.
Halvorsen BL, Carlsen MH, Phillips KM, Bøhn SK, Holte K, Jacobs DR Jr: Content of redox-active compounds (i.e. antioxidants) in foods consumed in the United States. Am J Clin Nutr 2006;84:95-135.
11.
Scalzo J, Politi A, Pellegrini N, Mezzetti B, Battino M: Plant genotype affects total antioxidant capacity and phenolic contents in fruit. Nutr 2005;21:207-213.
12.
Basu A, Rhone M, Lyons TJ: Berries: emerging impact on cardiovascular health. Nutr Rev 2010;68:168-177.
13.
Giampieri F, Tulipani S, Alvarez-Suarez JM, Quiles JL, Mezzetti B, Battino M: The strawberry: composition, nutritional quality, and impact on human health. Nutr 2012;28:9-19.
14.
Cao G, Russell RM, Lischner N, Prior RL: Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr 1998;128:2383-2390.
15.
Rissanen TH, Voutilainen S, Virtanen JK, et al: Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. J Nutr 2003;133:199-204.
16.
Mink PJ, Scrafford CG, Barraj LM, et al: Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85:895-909.
17.
Somerset SM, Johannot L: Dietary flavonoid sources in Australian adults. Nutr Cancer 2008;60:442-449.
18.
Wojdyło A, Figiel A, Oszmiański J: Effect of drying methods with the application of vacuum microwaves on the bioactive compounds, color, and antioxidant activity of strawberry fruits. J Agric Food Chem 2009;57:1337-1343.
19.
Parelman MA, Storms DH, Kirschke CP, Huang L, Zunino SJ: Dietary strawberry powder reduces blood glucose concentrations in obese and lean C57BL/6 mice, and selectively lowers plasma C-reactive protein in lean mice. Brit J Nutr 2012;108:1789-1799.
20.
Zunino SJ, Parelman MA, Freytag TL, Stephensen CB, Kelley DS, Mackey BE, et al: Effects of dietary strawberry powder on blood lipids and inflammatory markers in obese human subjects. Brit J Nutr 2012;108:900-909.
21.
Basu A, Xu Fu D, Wilkinson M, Simmons B, Wu M, Betts NM, et al: Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res 2010;30:462-469.
22.
Basu A, Wilkinson M, Penugonda K, Simmons B, Betts NM, Lyons TJ: Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: baseline and post intervention effects. Nutr J 2009;8:43.
23.
Jenkins DJ, Nguyen TH, Kendall C, Faulkner DA, Bashyam B, Kim IJ, et al: The effect of strawberries in a cholesterol-lowering dietary portfolio. Metab Clin Exper 2008;57:1636-1644.
24.
Jenkins DJA, Srichaikul K, Kendall DJA, Sievenpiper JL, Abdulnour S, Mirrahimi A, et al: The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia 2011;54:271-279.
25.
Paiva SA, Yeum KJ, Cao G, Prior RL, Russell RM: Postprandial plasma carotenoid responses following consumption of strawberries, red wine, vitamin C or spinach by elderly women. J Nutr 1998;128:2391-2394.
26.
Hannum SM: Potential impact of strawberries on human health; a review of the science. Crit Rev Food Sci Nutr 2004;44:1-17.
27.
Lazze MC, Pizzala R, Perucca P, Cazzalini O, Savio M, Forti L, et al: Anthocyanidins decrease endothelin-1 production and increase endothelial nitric oxide synthase in human endothelial cells. Mol Nutr Food Res 2006;50:44-51.
28.
Manzano S, Williamson G: Polyphenols and phenolic acids from strawberry and apple decrease glucose uptake and transport by human intestinal caco-2 cells. Mol Nutr Food Res 2010;54:1773-1780.
29.
Roy M, Sen S, Chakraborti AS: Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycation-induced hemoglobin modification. Life Sci 2008;82:1102-1110.
30.
Wilson T, Luebke JL, Morcomb EF, Carrell EJ, Leveranz MC, Kobs L, Schmidt TP, Limburg PJ, Vorsa N, Singh AP: Glycemic responses to sweetened dried and raw cranberries in humans with type 2 diabetes. J Food Sci 2010;75:H218-H223.
31.
DeFuria J, Bennett G, Strissel KJ, et al: Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr 2009;139:1510-1516.
32.
Tominaga Y, Mae T, Kitano M, Sakamoto Y, Ikematsu H, Nakagawa K: Licorice flavonoid oil effects body weight loss by reduction of body fat mass in over weight subjects. J Health Sci 2006;52:672-683.
33.
Sesso HD, Gaziano JM, Jenkins DJ, Buring JE: Strawberry intake, lipids, C-reactive protein, and the risk of cardiovascular disease in women. J Am Coll Nutr 2007;26:303-310.
34.
Giongo L, Bozza E, Caciagli P, Valente E, Pasquazzo MT, Pedrolli C, et al: Short-term blueberry intake enhances biological antioxidant potential and modulates inflammation markers in overweight and obese children. J Berry Res 2011;1:147-158.
35.
Basu A, Du M, Leyva MJ, Sanchez K, Betts NM, Wu M, Aston CE, Lyons TJ: Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 2010;140:1582-1587.
36.
Curtis PJ, Kroon PA, Hollands WJ, Walls R, Jenkins G, Kay CD, Cassidy A: Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J Nutr 2009;139:2266-2271.
37.
Burton-Freeman B, Linares A, Hyson D, Kappagoda T: Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. J Am Coll Nutr 2010;29:46-54.
38.
Henning SM, Seeram NP, Zhang Y, Li L, Gao K, Lee RP, et al: Strawberry consumption is associated with increased antioxidant capacity in serum. J Med Food 2010;13:116-122.
39.
Niki E: Antioxidant capacity: which capacity and how to assess it? J Berry Res 2011;1:169-176.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.